Smith & Nephew Plc Director/PDMR Shareholding (9220L)
18 Mai 2022 - 10:02AM
UK Regulatory
TIDMSN.
RNS Number : 9220L
Smith & Nephew Plc
18 May 2022
SMITH & NEPHEW PLC
18 May 2022
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE
REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY
PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND
PERSONS CLOSELY ASSOCIATED WITH THEM.
On 17 May 2022, Smith & Nephew plc (the "Company") received
notification of the following transactions as detailed below.
Reason for the notification
Initial notification Initial notification
/Amendment
------------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
------------------------------------------------
LEI 213800ZTMDN8S67S1H61
------------------------------------------------
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
Description of the Smith & Nephew plc SPON ADR American Depositary
financial instrument, Shares (ADS)
type of instrument
------------------------------------------------
Identification code ISIN: US83175M2052
------------------------------------------------
Nature of the transaction PDMR is a participant of the Company's Employee
Stock Purchase Plan, which on 12 May 2022
purchased American Depository Shares through
the Company's Dividend Re-Investment Plan
following the 2021 final dividend payment
on 11 May 2022.
------------------------------------------------
Date of Transaction 2022 - 05 - 12
------------------------------------------------
Place of Transaction New York Stock Exchange
------------------------------------------------
Total Ordinary
Share Holding
Total Ordinary as a % of
Share Holding the Company's
following ISC following
Name Director Price Aggregated the transaction the transaction
(Position) / PDMR ($) Volume information * *
Bradley Cannon
(President 99,528.87527
Orthopaedics, (including
Sports Medicine N/A Single 2,759.85329
& ENT) PDMR 29.7199 41.34469 Transaction in ADS') 0.01124%
---------- -------- --------- ------------- ----------------- -----------------
2,350.90991
Alison Parkes (including
( Chief Compliance N/A Single 406.33079
Officer) PDMR 29.7199 6.08717 Transaction in ADS') 0.00027%
---------- -------- --------- ------------- ----------------- -----------------
* including those held by Persons Closely Associated with the
Director/PDMR. All figures in these columns are stated to 5 decimal
places where applicable.
Sarah Carne
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFIFEDEFITLIF
(END) Dow Jones Newswires
May 18, 2022 04:02 ET (08:02 GMT)
Smith & Nephew (LSE:SN.)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Smith & Nephew (LSE:SN.)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024